Trial Profile
An open-label phase I/II study of humanized human milk fat globule-1 (THEREX) [monoclonal antibody HMFG1] in patients with locally advanced or metastatic breast cancer following prior anthracycline and taxane therapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs BTH 1704 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 18 Sep 2005 New trial record.